What Happened?
San Francisco, CA-based Vir-Biotechnology Appointed George Scangos as Chief Executive Officer
About the Company
Vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world`s most challenging infectious diseases for which solutions are non-existent or inadequate. Vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. The company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.
About the Person
George Scangos is Chief Executive Officer at Vir Biotechnology. Previously, George held various senior HR leadership roles in the industry.
Info Source
News
Short Profile